Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

29,788 signal articles · 39 in last 24h · 148,487 total before filter · latest 1h ago
39last 24h
976last 7d
108● bullish (7d)
121● bearish (7d)
212publishers
AllMacro370Earnings114M&A99Regulatory8Product11Analyst9
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Netflix (NFLX) Gets a Bullish $110 Target: What’s Driving the Outlook?
Insider Monkey13h agoneutral
Netflix (NFLX) Gets a Bullish $110 Target: What’s Driving the Outlook?

On September 14, Evercore ISI raised its price target for Netflix, Inc. (NASDAQ:NFLX) from $100 to $110 while maintaining its Outperform rating. The research firm rolled its valuation framework forward to 2028 and applied a multiple of 25 times its 2028 EPS estimate. The new price target represents more than 40% upside from the share […]

Ross Stores (ROST), What Is Behind The Fresh Attention Now?
Simply Wall St.14h agoneutral
Ross Stores (ROST), What Is Behind The Fresh Attention Now?

Ross Stores (ROST) recently refreshed its board, adding technology executive Shelley H. Bransten and consumer investor Christian B. Johnson, while long-serving director Sharon D. Garrett prepares to retire after more than two decades of service. The Ross Stores share price has eased over the past month, with a 1-month share price return of 3.44% and a 7-day share price return of 1.79% lower. At the same time, the stock shows stronger momentum over longer periods, including a 24.01%...

Is Iovance Biotherapeutics (IOVA) Trading At A Premium To Sales?
Simply Wall St.14h agoneutral
Is Iovance Biotherapeutics (IOVA) Trading At A Premium To Sales?

Iovance Biotherapeutics has seen its stock price move sharply in recent years, which puts fresh attention on whether the current valuation lines up with the scale of its sales. For anyone looking at Iovance today, the key issue is how that share price stacks up against the revenue base supporting it. The stock has returned 400.0% over the past year, which raises a direct question about how much sales performance can underpin that kind of move. The business model, focused on developing and...

Citi Forecasts Widening Memory Chip Shortages Through 2031 as AI Demand Expands
InvestorsHub14h agoneutral
Citi Forecasts Widening Memory Chip Shortages Through 2031 as AI Demand Expands

Citi expects shortages across the global memory semiconductor market to deepen through 2031, driven by increasing demand for high-bandwidth memory (HBM), DRAM and NAND as artificial intelligence systems adopt continual learning. In a research note published Monday, the investment bank identified continual learning as a potential central theme in AI development over the next five years.

These 6 Massive Dividend Yields May Be Too Good to Be True
24/7 Wall St.15h agoneutral
These 6 Massive Dividend Yields May Be Too Good to Be True

A fat dividend yield can signal a stock worth buying or a company quietly falling apart, and telling the difference requires looking past the payout itself at the cash flow, debt load, and share price collapse hiding behind the number.

Why XPeng (XPEV) Is Getting Fresh Attention Now
Simply Wall St.15h agoneutral
Why XPeng (XPEV) Is Getting Fresh Attention Now

XPeng (NYSE:XPEV) is back in the spotlight after unveiling its G9L next generation AI flagship SUV in Beijing, combining physical AI features, global safety standards, and dual China Europe production. XPeng’s recent G9L announcement comes after a tougher stretch for the stock, with the share price down 48.02% year to date and the 1-year total shareholder return falling 50.97%, while shorter term moves suggest momentum has yet to meaningfully turn. Scan beyond XPeng and line up other physical...

Rockwell Automation (ROK) Joins Project Glasswing, Is The Stock Still Undervalued?
Simply Wall St.15h agoneutral
Rockwell Automation (ROK) Joins Project Glasswing, Is The Stock Still Undervalued?

Rockwell Automation (ROK) has joined Anthropic’s Project Glasswing, giving its security teams controlled access to Claude Mythos 5 to probe software vulnerabilities across connected industrial systems that manufacturers use every day. The recent Project Glasswing news comes amid a mixed price backdrop for Rockwell Automation, with a 1-day share price return of 1.36% and a 90-day share price return that declined 12.28% from recent highs. At the same time, the 1-year total shareholder return of...

CrowdStrike (CRWD) Lands Forrester Leadership Nod As AI Security Ties Deepen
Simply Wall St.15h agoneutral
CrowdStrike (CRWD) Lands Forrester Leadership Nod As AI Security Ties Deepen

CrowdStrike Holdings (NasdaqGS:CRWD) was named a Leader in The Forrester Wave Q3 2026 report on external threat intelligence services. The Forrester evaluation highlights CrowdStrike’s approach to Threat AI as a foundation for next generation security operations. CrowdStrike announced new integrations with Salt Security, Horizon3, and Nord Security to broaden its AI driven security and intelligence platform. For investors, the Forrester recognition and new partner integrations are useful...

How Investors Are Reacting To Ultragenyx Pharmaceutical (RARE) First-In-Disease Gene Therapy Approval For FAYUVI
Simply Wall St.15h agoneutral
How Investors Are Reacting To Ultragenyx Pharmaceutical (RARE) First-In-Disease Gene Therapy Approval For FAYUVI

In September 2026, Ultragenyx Pharmaceutical received full U.S. FDA approval for FAYUVI (UX111), the first-ever treatment for pediatric patients with Sanfilippo syndrome Type A, along with a Priority Review Voucher. This approval not only addresses a previously untreated ultra-rare, fatal neurodegenerative disease but also expands Ultragenyx’s commercial gene therapy portfolio and manufacturing footprint in the U.S. We’ll now explore how FAYUVI’s first-in-disease approval and the associated...

FedEx (FDX) Stock Could Be 42% Undervalued On New Import Fees
Simply Wall St.15h agoneutral
FedEx (FDX) Stock Could Be 42% Undervalued On New Import Fees

FedEx has delivered a strong multi year share price run, which now puts a spotlight on whether the current US$303.65 stock price is backed by the cash the business is expected to generate. With a Discounted Cash Flow (DCF) view available, the key issue is how that intrinsic value stacks up against where the market is trading today. FedEx shares are up 83.9% over 5 years, which raises the question of how much future cash flow the market is already baking into the valuation. New fees on a...

India's Silicon Valley Is Straining Under Its Own Growth
Bloomberg15h agoneutralVIDEO
India's Silicon Valley Is Straining Under Its Own Growth

Bangalore helped turn India into a global hub for software services, tech talent and outsourcing, building an ecosystem that now supports multinational firms, domestic startups and capital. But the city's success has also become one of its biggest weaknesses. India still lacks the depth of capital available in the US and China, while Bangalore's physical infrastructure has struggled to keep pace with private-sector growth. At the same time, southern India's rising economic power is colliding with demographic and political shifts that could threaten its representation in the country's Central Government, which helps support the growth that cities like Bangalore have enjoyed.